Literature DB >> 2644050

Train-of-four ratio after antagonism of atracurium with edrophonium: influence of different priming doses of edrophonium.

M Naguib1.   

Abstract

This study was designed to investigate the effect of different priming doses of edrophonium on the relationship between the the recovery of the first twitch of the train-of-four (T1) and train-of-four (TOF) ratio. This relationship was studied after the administration of the full dose of the antagonist in all groups. Edrophonium 1.0 mg.kg-1 was administered either in a single bolus dose (Group I, controls) or in an initial dose of 0.05, 0.1, 0.15 or 0.2 mg.kg-1 followed one minute later by the remainder of the 1.0 mg.kg-1 dose in Groups II to V. Reversal was attempted at the ten per cent spontaneous recovery of twitch height (T1) from atracurium-induced neuromuscular blockade. Of all the groups studied, Group V had a significantly greater recovery in the TOF ratio at any given T1 value. When first twitch tension (T1) had recovered to 100 per cent of the control, it was found for the same tension that the TOF ratio was greater in Group V, being 0.75 compared to 0.63, 0.65, 0.65 and 0.64 in Groups I to IV respectively. The implication is that this differential ability to reverse fade (or prejunctional activity) may be involved in the acceleration of recovery.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644050     DOI: 10.1007/BF03010882

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  12 in total

1.  The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium.

Authors:  H E Barber; T N Calvey; K T Muir
Journal:  Br J Pharmacol       Date:  1979-08       Impact factor: 8.739

2.  Accelerated reversal of atracurium blockade with priming doses of edrophonium.

Authors:  M Naguib; M Abdulatif; G H Absood
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

3.  Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

4.  Priming with anti-cholinesterases--the effect of different priming doses of edrophonium.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

Review 5.  Clinical assessment of neuromuscular transmission.

Authors:  J Viby-Mogensen
Journal:  Br J Anaesth       Date:  1982-02       Impact factor: 9.166

Review 6.  Prejunctional and postjunctional cholinoceptors at the neuromuscular junction.

Authors:  W C Bowman
Journal:  Anesth Analg       Date:  1980-12       Impact factor: 5.108

7.  Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.

Authors:  F Donati; A Ferguson; D R Bevan
Journal:  Anesth Analg       Date:  1983-03       Impact factor: 5.108

8.  A microelectrode study of the effects of atracurium on neuromuscular transmission.

Authors:  T Otagiri; M D Sokoll
Journal:  Anesth Analg       Date:  1986-04       Impact factor: 5.108

9.  Assessment of the presynaptic effect of atracurium. Train-of-four and tetanic stimulation in in vitro preparations.

Authors:  F A Wali
Journal:  Acta Anaesthesiol Scand       Date:  1985-10       Impact factor: 2.105

10.  Accelerated reversal of atracurium blockade with divided doses of neostigmine.

Authors:  M Abdulatif; M Naguib
Journal:  Can Anaesth Soc J       Date:  1986-11
View more
  2 in total

1.  Edrophonium priming for antagonism of atracurium neuromuscular blockade.

Authors:  J E Szalados; F Donati; D R Bevan
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

2.  Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.

Authors:  M Naguib; M Abdulatif
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.